Dec 31 (Reuters) - Some U.S. stocks on the move on Monday:
Wall Street mostly edged higher, with the S&P 500 on track for double-digit gains for the year, as politicians bargained for a deal to avert the “fiscal cliff”. The Dow Jones industrial average was down 0.07 percent, the Standard & Poor’s 500 Index was up 0.24 percent and the Nasdaq Composite Index was up 0.66 percent.
** APPLE INC, $523.10, up 3 pct (1208 ET)
The company has agreed to withdraw patent claims against a new Samsung phone with a high-end display after Samsung said it was not offering to sell the product in the crucial U.S. market.
** BANK OF AMERICA CORP, $11.43, up 0.63 pct (1201 ET)
** WELLS FARGO & CO, $33.75, down 0.47 pct (1202 ET)
** JPMORGAN CHASE & CO, $43.18, down 0.14 pct (1202 ET)
** CITIGROUP INC, $38.87, down 0.36 pct (1203 ET)
U.S. regulators are nearing a $10 billion settlement with several banks that would end the government’s efforts to hold lenders responsible for faulty foreclosure practices, the New York Times reported, citing people with knowledge of the talks.
** CAL-MAINE FOODS INC, $39.95, down 10 pct (1203 ET)
The U.S. egg supplier posted a lower second-quarter profit, hurt by higher feed costs and acquisition-related expenses.
** BPZ RESOURCES, $3.16, up 9 pct (1158 ET)
BPZ Energy, which trades as BPZ Resources, said the Peruvian government has allowed it to partner with Pacific Rubiales Corp to develop the Block Z-1 oilfield.
** ALON USA ENERGY INC, $16.83, up 11 pct (1203 ET)
Goldman Sachs started coverage on the oil refiner’s stock with a “buy” rating and a target price of $21, according to Theflyonthewall.com.
** HERBALIFE LTD, $31.82, up 8 pct (1208 ET)
The nutritional supplements seller’s stock continued its recovery from a 40 percent four-day slide spurred by William Ackman’s announcement that he was shorting it. It has gained 22 percent since Dec. 24.
** LEXICON PHARMACEUTICALS INC, $2.24, up 17 pct (0108 ET)
The stock touched a two-month high of $2.21. About 4.8 million shares had changed hands by 0108 ET, more than four times the 10-day average, although there was no news on the company. Late-stage trial data from Lexicon’s drug to treat a condition related to bowel cancer is expected in the first quarter of 2013. Earlier this month, U.S. health regulators fast-tracked Lexicon’s oral drug to treat diarrhea-predominant irritable bowel syndrome.
** US AIRWAYS GROUP INC, $13.62, up 6 pct (1233 ET)
In a step that potentially could ease the way for a merger of American Airlines parent AMR Corp and US Airways Group, the board of American's pilots union approved an interim labor framework should the two carriers proceed with a combination to take AMR out of bankruptcy-court protection, the Wall Street Journal reported. (link.reuters.com/tax84t)
** DUFF & PHELPS, $15.70, up 20 pct (1204 ET)
** CARLYLE GROUP, $25.98, up 0.50 pct (1204 ET)
A group of private equity firms, including the Carlyle Group, struck a deal on Sunday to buy financial advisory and investment banking firm Duff & Phelps Corp for about $665.5 million. Duff & Phelps said the firms will pay $15.55 per share to stockholders. The other buyers in the consortium are Stone Point Capital, Pictet & Cie and Edmond de Rothschild Group.
** FACEBOOK INC, $26.45, up 2 percent (1209 ET)
Stifel Nicolaus raised its price target on the stock. The brokerage said the social network can leverage its database of birthdays to focus on selling high-margin gifts. This would allow it to stay out of direct competition with Amazon.Com Inc and eBay Inc merchant platforms. BMO Capital Markets reinstated coverage of the stock.
** QIHOO 360 TECHNOLOGY CO LTD, $28.82, up 5 pct (1209 ET)
Shares of the Chinese internet company were up on market chatter that it is likely that its search engine, so.com, will work with Google Inc to monetize its search functions, said T.H. Capital Research analyst Tian Hou.
** BRADY CORP, $33.15, up 1 pct (1015 ET)
The identification products maker said it bought Precision Dynamics Corp from private equity firm Water Street Healthcare Partners for $300 million.
** BRISTOL MYERS-SQUIBB CO, $32.30, up 1.25 pct (1206 ET)
** PFIZER INC, $24.81, down 0.31 pct (1205 ET)
U.S. health regulators approved clot prevention drug Eliquis, developed by Bristol Myers-Squibb and Pfizer, for treatment in patients with atrial fibrillation, or irregular heartbeats.
** NETFLIX INC, $91.80, up 3 pct (1206 ET)
The video rental company doubled Chief Executive Reed Hastings’ 2013 salary to $4 million, after a pay cut this year, the company disclosed in a regulatory filing late on Friday.
** MAGELLAN HEALTH SERVICES INC, $49.74 down 4 pct (1208 ET)
One of Magellan’s customers said it would not renew its behavioural health management services contract. The loss of the contract is not expected to hurt the company’s 2013 forecast it said. (Compiled by Arpita Mukherjee in Bangalore)